Trevi Therapeutics, Inc.
$11.88
-0.23 (-1.90%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -21.9%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -36.9%
Own TRVI?
See how TRVI contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.